Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk?
André, E.; Hacquard, M.; Alnot, Y.; de Maistre, E.; Lecompte, T.
Thrombosis and Haemostasis 98(3): 693-694
2007
ISSN/ISBN: 0340-6245 PMID: 17849066 Document Number: 607569
Document emailed within 1 workday
Related Documents
Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488James O' Donnell and Michael Laffan 2001: Elevated Plasma Factor VIII Levels - a Novel Risk Factor for Venous Thromboembolism Clinical Laboratory 47(1-2): 1-6
Jones, M.P.; Carrington, L.; Cutting, M.; Alving, B. 1997: Variation in test results for APC resistance with factor V deficient plasma from different donors Thrombosis and Haemostasis 77(3): 601
Giordano, P.; Sabato, V.; Schettini, F.; De Mattia, D.; Iolascon, A. 1997: Resistance to activated protein C as a risk factor of stroke in a thalassemic patient Haematologica 82(6): 698-700
He, W.J.; Hu, Y.; Zhang, X.P.; Hong, M.; Guo, T.; Wei, W.N.; Song, S.J. 2008: Activated protein C ratio, plasma tissue factor activity and activated factor VIi in Chinese patients with coronary heart disease European Journal of Medical Research 13(2): 47-51
Svensson, A.M.; Whiteley, G.R.; Callas, P.W.; Bovill, E.G. 2006: SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occurring before age 40 Thrombosis and Haemostasis 96(6): 725-730
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Hernández-Jerónimo, J.; Pérez-Campos, E.; Matadamas, C.ém.; Majluf-Cruz, A. 2003: A new thrombophilia risk factor: the increase of plasma factor VIIi Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(4): 448-457
Heinemann, L.A.J.; Kluft, C.; Spannagl, M.; de Maat, M.P.M. 2002: The association between extrinsic activated protein C resistance and venous thromboembolism in women Contraception 66(5): 297-304
Colucci, M.; Ciavarella, N.; Giliberti, M.G.; Semeraro, N. 1994: Resistance to activated protein C (APC): influence of factor V levels Thrombosis and Haemostasis 72(6): 987-988
Eich, S.; Kusch, M.; Grundmann, C.; Hanker, C.; Seitz, R.; König, H. 2003: Factor VIII determination in patient's plasma and concentrates: a novel test equally suited for both matrices Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(4): 347-353
De Stefano, V.; Leone, G. 1995: Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia Haematologica 80(4): 344-356
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Leroy-Matheron, C.; Levent, M.; Pignon, J.M.; Mendonça, C.; Gouault-Heilmann, M. 1996: The 1691 G-->A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients Thrombosis and Haemostasis 75(1): 4-10
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Rolla, R.; Vidali, M.; Meola, S.; Pollarolo, P.; Pergolini, P.; Bellomo, G. 2011: Estimating the Cost of Redundancy in Molecular Diagnostics: The Case of Activated Protein C Resistance and Factor V Leiden Clinical Laboratory 57(9-10): 711-717
Levoir, D.; Aubertin, J.M.; Alhenc-Gelas, M.; Bloch, F.; Becheur, H.; Petite, J.P. 1995: A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V Gastroenterologie Clinique et Biologique 19(8-9): 729-731
Martorell, J.R.; Muñoz-Castillo, A.; Gil, J.L. 1995: False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract Thrombosis and Haemostasis 74(2): 796-797
Lindqvist, P.G.; Svensson, P.J.; Dahlbäck, B.; Marsál, K. 1998: Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss--a possible evolutionary selection mechanism Thrombosis and Haemostasis 79(1): 69-73